All products / DCC0844
CAT. NO. DCC0844
Azd1897
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $750 USDRequest a quote / confirm availability → |
| 250 mg | $1,200 USDRequest a quote / confirm availability → |
| 1 g | $2,500 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
AZD1897 is a PIM1, PIM2, and PIM3 inhibitor with IC50 values of less than 3 nM for these three PIM kinases. AZD1897 exhibits anticancer activity and synergistically inhibits the activity of acute myeloid leukemia (AML) cells in combination with Capivasertib (HY-15431). This synergistic inhibitory effect is achieved through the inhibition of the mTOR and MCL1 pathways.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DCC0844 |
|---|---|
| Product name | Azd1897 |
| CAS | 1204181-93-0 |
| Molecular formula | C18H23N3O3S |
| Molecular weight | 361.46 |
| Purity | >98% |
| SMILES | CC(C)Oc1cccc(/C=C2\SC(=O)NC2=O)c1N1CCC[C@@H](N)C1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Azd1897 (DCC0844)